CE Workshop #2 – 1.5 credits – Innovations in Neuroimaging Modalities (Low-income Professional/Student)

$18.75

Time: 12:30pm – 2:00pm EST

CE: 1.5 credit hours

After this workshop, you will be able to:

  1. Explain the value of biomarkers and cognitive measures to diagnosis epilepsy and dementia
  2. Compare “gold” standard ESM to ECoG-based language mapping with deep learning approaches for pre-surgical planning
  3. List cognitive outcomes in cognitively-unimpaired carriers with familial Alzheimer’s disease

Time: 12:30pm – 2:00pm EST

CE: 1.5 credit hours

This course will highlight translational research and innovations in human brain mapping in order to understand complex diseases across the lifespan. In clinical neurology, patients can present with the exact same group of symptoms (autism, generalized seizures called infantile spasms) despite a disparate distribution of causal focal lesions, including strokes, tumors, or malformations of cortical development. Through a novel approach called lesion network mapping (LNM), Dr. Peters will demonstrate how shared network properties of specific phenotypes can be identified. He will also present some forward-looking ideas about the application of deep learning and medical crowd-sourcing to tackle rare diseases like Tuberous Sclerosis Complex. Epilepsy surgery often remains the only possible treatment option to achieve seizure freedom and improve quality of life in patients with pharmacoresistant epilepsy. However, the overlap between the resection site and a neural substrate supporting language and motor functions might result in severe post-surgical deficits. To avoid pos-surgical morbidity and expand surgical treatment options, the innovative adaptive neurotechnology approaches, powered by machine learning and deep learning algorithms, are being developed to create functional maps in real-time and guide epilepsy surgery. Dr. Korostenskaja will discuss the current state of this technological development in the field of epilepsy and tumor surgery and its future perspectives. Finally, Dr. Quiroz will discuss recent developments in biomarkers of preclinical Alzheimer’s disease, including her group’s work with autosomal dominant Alzheimer’s disease, multimodal neuroimaging methods and digital assessments.

 

To receive CE credit, you will be required to complete a post-activity evaluation for each workshop you attend. You will receive a certificate of completion.

 

Scroll to Top